Biological
Carcinoembryonic Antigen RNA-pulsed DC Cancer Vaccine clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 1997
How studies write it
Studies that test it under each name
Studies by the year they started
3 studies that test it; most in 1998 (2)
| Year | Studies |
|---|---|
| 1997 | 1 |
| 1998 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
- Phase 2
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 3
Duke University (2) · Duke Cancer Institute (1)
Studies
Open first, then newest update. How each study uses Carcinoembryonic Antigen RNA-pulsed DC Cancer Vaccine is read from its arms, and is right about nine times in ten.
Testing it · 3
- Immunotherapy in Treating Patients With Metastatic Breast CancerTerminatedPhase 1/2Duke UniversityNCT00003432Written as carcinoembryonic antigen RNA-pulsed DC cancer vaccine
- Immunotherapy in Treating Patients With Resected Liver Metastases From Colon CancerCompletedPhase 1/2Duke Cancer InstituteNCT00003433Written as carcinoembryonic antigen RNA-pulsed DC cancer vaccine
- Biological Therapy in Treating Patients With Metastatic CancerCompletedPhase 1Duke UniversityNCT00004604Written as CEA RNA-pulsed DC cancer vaccine